Market Cap 854.33M
Revenue (ttm) 292.65M
Net Income (ttm) 119.42M
EPS (ttm) N/A
PE Ratio 6.80
Forward PE 8.09
Profit Margin 40.81%
Debt to Equity Ratio 1.33
Volume 599,918
Avg Vol 415,918
Day's Range N/A - N/A
Shares Out 64.87M
Stochastic %K 29%
Beta 0.60
Analysts Sell
Price Target $14.83

Company Profile

Bain Capital Specialty Finance, Inc. is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA betwee...

Industry: Asset Management
Sector: Financial Services
Phone: 617 516 2000
Fax: 617 516 2010
Address:
200 Clarendon Street, Boston, United States
DonCorleone77
DonCorleone77 Feb. 2 at 3:33 AM
$F $ORCL $PHAR $CG $BCSF Top five weekend stock stories: 1) Ford (F) held discussions with Xiaomi (XIACF) over a partnership to help Chinese carmakers gain a foothold in the U.S., Demetri Sevastopulo, Christian Davies, Kana Inagaki, and Gloria Li of The Financial Times reports, citing four people familiar with the matter. During preliminary discussions, Ford explored forming a joint venture with Xiaomi to create EVs in the U.S., the sources added. Ford has also discussed with BYD (BYDDF) about a potential U.S. collaboration. 2) Oracle (ORCL) announced its full calendar year 2026 plan to fund the expansion of its Oracle Cloud Infrastructure business. Oracle is raising money in order to build additional capacity to meet the contracted demand from its largest Oracle Cloud Infrastructure customers. Oracle expects to raise $45 to $50 billion of gross cash proceeds during the 2026 calendar year. The company plans to achieve its funding objective by using a balanced combination of debt and equity financing to maintain a solid investment-grade balance sheet. 3) Pharming (PHAR) announced that the U.S. Food and Drug Administration, FDA, has issued a Complete Response Letter, CRL, to its supplemental New Drug Application, sNDA, for Joenja, an oral, selective phosphoinositide 3-kinase delta inhibitor, as a treatment for children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome, APDS, a rare primary immunodeficiency. The FDA raised an issue with the potential for underexposure in lower weight pediatric patients. As a result, the FDA has requested additional pediatric pharmacokinetic data to reassess the proposed pediatric doses and confirm that children in the lower weight dose groups can achieve exposure levels comparable to the approved adult and adolescent regimen. The letter also identified an issue with one of the analytical methods used for production batch testing, and the FDA requested additional data and clarification on this point. 4) Carlyle (CG) has started exploratory talks with UAE investors to bring in partners should its agreement to purchase Lukoil's international assets proceed, Shadia Nasralla and Anna Hirtenstein of Reuters reports, citing three sources with knowledge of the process. 5) Bain Capital (BCSF) has finalized plans to acquire FineToday in a deal set to be worth $1.29B, Reuters reports, citing Nikkei. CVC Capital Partners intends to divest all of FineToday's shares.
1 · Reply
cholle
cholle Dec. 31 at 6:43 PM
$BCSF +0.46% +1.07% DIVIDEND 1/26/26 = 20.73% APR
0 · Reply
Cheatah
Cheatah Dec. 28 at 10:29 PM
$BCSF we getting a special of .15 separate from the regular divy! Nice!
0 · Reply
WireframeWhisper
WireframeWhisper Dec. 27 at 2:37 PM
$BCSF Valuation sensitivity is high because visibility is uneven; commercial execution has to tighten in upcoming quarters — a credible cadence of milestones would shift sentiment. The thesis tightens only when delivery matches ambition.
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 11:48 AM
Keefe, Bruyette & Woods has adjusted their stance on Bain Capital Specialty ( $BCSF ), setting the rating to Outperform with a target price of 16.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 3 at 4:34 PM
$BCSF Share Price: $14.26 Contract Selected: Jul 17, 2026 $15 Calls Buy Zone: $0.17 – $0.21 Target Zone: $0.28 – $0.35 Potential Upside: 58% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
topstockalerts
topstockalerts Nov. 17 at 5:00 PM
Bain Capital has agreed to acquire private golf-club operator Concert Golf Partners from Clearlake Capital in a deal valuing the company at more than $1.3 billion including debt, according to Bloomberg. The transaction, involving Bain’s private-equity and real-estate strategies, gives Clearlake a full exit. Based in Lake Mary, Florida, Concert Golf owns and operates 39 U.S. golf clubs. Financial terms weren’t disclosed. Clearlake first invested in 2022 and expanded the portfolio with 14 acquisitions, significantly growing Concert Golf’s national footprint. The deal underscores ongoing private-equity interest in the golf industry. $BCSF
0 · Reply
Cheatah
Cheatah Nov. 13 at 8:52 PM
$BCSF earnings could be better and could be worse. 🤷‍♂️ NII was good @.45 /sh. NAV/sh down to 17.40 from 17.56. Not yet a concern but certainly worth monitoring. They will need to reverse this trend of small declines in the NAV/sh.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 12:06 PM
Keefe, Bruyette & Woods has adjusted their stance on Bain Capital Specialty ( $BCSF ), setting the rating to Market Perform with a target price of 17 → 16.
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 3:12 PM
Wells Fargo updates rating for Bain Capital Specialty ( $BCSF ) to Overweight, target set at 16 → 15.
0 · Reply
Latest News on BCSF
Can Bain Capital Specialty Finance Weather BDC Headwinds?

Oct 13, 2025, 6:09 AM EDT - 4 months ago

Can Bain Capital Specialty Finance Weather BDC Headwinds?


BDC Weekly Review: Let's Take A Deep Breath On Dividend Coverage

Aug 31, 2025, 6:53 AM EDT - 5 months ago

BDC Weekly Review: Let's Take A Deep Breath On Dividend Coverage


Buy 9 Ideal Safer Dividend Power August Dogs

Aug 21, 2025, 4:33 AM EDT - 5 months ago

Buy 9 Ideal Safer Dividend Power August Dogs

AOMR BSM CIM FBRT FPI GAIN GECC


Discounts And 10%+ Yields: 2 BDCs To Buy Now

Aug 2, 2025, 9:15 AM EDT - 6 months ago

Discounts And 10%+ Yields: 2 BDCs To Buy Now

BIZD CCAP MAIN TSLX


Bain Capital Specialty Finance: I'm Buying The Dip

Mar 14, 2025, 10:29 AM EDT - 11 months ago

Bain Capital Specialty Finance: I'm Buying The Dip


Private Equity Investment In Japan Soars

Jan 28, 2025, 12:17 PM EST - 1 year ago

Private Equity Investment In Japan Soars

BX CG KKR


BDC Weekly Review: Key Q3 Earnings Trends

Nov 30, 2024, 6:54 AM EST - 1 year ago

BDC Weekly Review: Key Q3 Earnings Trends

BBDC GSBD PSEC TPVG


Don't Miss Out On Bain Capital Specialty Finance

Nov 17, 2024, 2:58 PM EST - 1 year ago

Don't Miss Out On Bain Capital Specialty Finance


BDC Weekly Review: Q2 Wrap-Up

Aug 31, 2024, 4:19 AM EDT - 1 year ago

BDC Weekly Review: Q2 Wrap-Up


BDC Weekly Review: PSEC Gets Bad Press

Aug 23, 2024, 10:03 PM EDT - 1 year ago

BDC Weekly Review: PSEC Gets Bad Press

BXSL NCDL PSEC


DonCorleone77
DonCorleone77 Feb. 2 at 3:33 AM
$F $ORCL $PHAR $CG $BCSF Top five weekend stock stories: 1) Ford (F) held discussions with Xiaomi (XIACF) over a partnership to help Chinese carmakers gain a foothold in the U.S., Demetri Sevastopulo, Christian Davies, Kana Inagaki, and Gloria Li of The Financial Times reports, citing four people familiar with the matter. During preliminary discussions, Ford explored forming a joint venture with Xiaomi to create EVs in the U.S., the sources added. Ford has also discussed with BYD (BYDDF) about a potential U.S. collaboration. 2) Oracle (ORCL) announced its full calendar year 2026 plan to fund the expansion of its Oracle Cloud Infrastructure business. Oracle is raising money in order to build additional capacity to meet the contracted demand from its largest Oracle Cloud Infrastructure customers. Oracle expects to raise $45 to $50 billion of gross cash proceeds during the 2026 calendar year. The company plans to achieve its funding objective by using a balanced combination of debt and equity financing to maintain a solid investment-grade balance sheet. 3) Pharming (PHAR) announced that the U.S. Food and Drug Administration, FDA, has issued a Complete Response Letter, CRL, to its supplemental New Drug Application, sNDA, for Joenja, an oral, selective phosphoinositide 3-kinase delta inhibitor, as a treatment for children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome, APDS, a rare primary immunodeficiency. The FDA raised an issue with the potential for underexposure in lower weight pediatric patients. As a result, the FDA has requested additional pediatric pharmacokinetic data to reassess the proposed pediatric doses and confirm that children in the lower weight dose groups can achieve exposure levels comparable to the approved adult and adolescent regimen. The letter also identified an issue with one of the analytical methods used for production batch testing, and the FDA requested additional data and clarification on this point. 4) Carlyle (CG) has started exploratory talks with UAE investors to bring in partners should its agreement to purchase Lukoil's international assets proceed, Shadia Nasralla and Anna Hirtenstein of Reuters reports, citing three sources with knowledge of the process. 5) Bain Capital (BCSF) has finalized plans to acquire FineToday in a deal set to be worth $1.29B, Reuters reports, citing Nikkei. CVC Capital Partners intends to divest all of FineToday's shares.
1 · Reply
cholle
cholle Dec. 31 at 6:43 PM
$BCSF +0.46% +1.07% DIVIDEND 1/26/26 = 20.73% APR
0 · Reply
Cheatah
Cheatah Dec. 28 at 10:29 PM
$BCSF we getting a special of .15 separate from the regular divy! Nice!
0 · Reply
WireframeWhisper
WireframeWhisper Dec. 27 at 2:37 PM
$BCSF Valuation sensitivity is high because visibility is uneven; commercial execution has to tighten in upcoming quarters — a credible cadence of milestones would shift sentiment. The thesis tightens only when delivery matches ambition.
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 11:48 AM
Keefe, Bruyette & Woods has adjusted their stance on Bain Capital Specialty ( $BCSF ), setting the rating to Outperform with a target price of 16.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 3 at 4:34 PM
$BCSF Share Price: $14.26 Contract Selected: Jul 17, 2026 $15 Calls Buy Zone: $0.17 – $0.21 Target Zone: $0.28 – $0.35 Potential Upside: 58% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
topstockalerts
topstockalerts Nov. 17 at 5:00 PM
Bain Capital has agreed to acquire private golf-club operator Concert Golf Partners from Clearlake Capital in a deal valuing the company at more than $1.3 billion including debt, according to Bloomberg. The transaction, involving Bain’s private-equity and real-estate strategies, gives Clearlake a full exit. Based in Lake Mary, Florida, Concert Golf owns and operates 39 U.S. golf clubs. Financial terms weren’t disclosed. Clearlake first invested in 2022 and expanded the portfolio with 14 acquisitions, significantly growing Concert Golf’s national footprint. The deal underscores ongoing private-equity interest in the golf industry. $BCSF
0 · Reply
Cheatah
Cheatah Nov. 13 at 8:52 PM
$BCSF earnings could be better and could be worse. 🤷‍♂️ NII was good @.45 /sh. NAV/sh down to 17.40 from 17.56. Not yet a concern but certainly worth monitoring. They will need to reverse this trend of small declines in the NAV/sh.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 12:06 PM
Keefe, Bruyette & Woods has adjusted their stance on Bain Capital Specialty ( $BCSF ), setting the rating to Market Perform with a target price of 17 → 16.
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 3:12 PM
Wells Fargo updates rating for Bain Capital Specialty ( $BCSF ) to Overweight, target set at 16 → 15.
0 · Reply
IHadSkillz
IHadSkillz Oct. 9 at 3:50 PM
$ARCC guys the pain is not over. They are trying to get to capitulation where retail gives up. Its bdc across the board. I have seen this over and over. May go down another 10 percent. Just hold. $BCSF
1 · Reply
IHadSkillz
IHadSkillz Oct. 8 at 12:59 PM
$BCSF bounce a bit u dog
0 · Reply
IHadSkillz
IHadSkillz Sep. 30 at 4:02 PM
$BCSF short term bottom $ARCC
0 · Reply
Okadarlan
Okadarlan Sep. 30 at 9:38 AM
$BCSF $OBDE $FCPT and $CCAP on sale today.
1 · Reply
redrussian
redrussian Sep. 25 at 1:47 PM
$BCSF comin back off dip 14.48
1 · Reply
IHadSkillz
IHadSkillz Sep. 24 at 5:34 PM
$BCSF strong buy rating with @ZacksResearch and way below NAV. May have hit short term bottom/channel. Liking it for a play now
0 · Reply
redrussian
redrussian Sep. 24 at 4:15 PM
$BCSF added on this dip 14.25, BTW stocks that pay div usually go down after payout, good rating off zacks, will ride back to norm 15.75ish, and upgraded to pt16
1 · Reply
IHadSkillz
IHadSkillz Sep. 24 at 3:07 PM
$ARCC $BCSF both are decent bdcs. What gives on this recent dump. The modest rate cut led in fact to rates going up which will not hurt bdcs and their spreads. There is no real news. So what gives?
3 · Reply
IHadSkillz
IHadSkillz Sep. 24 at 2:53 PM
$BCSF will enter at 14.20. If it hits that today will pull off and wait until 14.
0 · Reply
redrussian
redrussian Sep. 24 at 1:26 PM
$BCSF 14.52 bottom of channel again, pt 15.65
1 · Reply
IHadSkillz
IHadSkillz Sep. 16 at 6:45 PM
$BCSF below targets mid 16s and below nav with low beta and pe ratio. Seems like a price that should rise yet sinks.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 11 at 11:36 AM
$BCSF Excellent article that nails exactly where BCSF stands right now. So if you want to update your BCSF knowledge or get acquainted with BCSF, this is a must read. https://beyondspx.com/quote/BCSF/analysis/bcsf-core-middle-market-prowess-fuels-consistent-shareholder-returns
0 · Reply